ロード中...
JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients
BACKGROUND: The use of natalizumab in multiple sclerosis (MS) may favour JC virus reactivation; this phenomenon is usually asymptomatic but can, albeit rarely, evolve into frank progressive multifocal leucoencephalopathy (PML). METHODS: JCV-specific CD8+ T lymphocytes were evaluated by flow cytometr...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3558446/ https://ncbi.nlm.nih.gov/pubmed/23232085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-10-248 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|